Tyra Biosciences Inc
NASDAQ:TYRA
Tyra Biosciences Inc
NASDAQ:TYRA
Price:
37.01
USD
2.18%
Market Closed
Market Cap:
$2B
Cash Flow Statement
Cash Flow Statement
Tyra Biosciences Inc
Tyra Biosciences Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
(9)
|
(12)
|
(16)
|
(20)
|
(26)
|
(37)
|
(46)
|
(52)
|
(55)
|
(52)
|
(51)
|
(59)
|
(69)
|
(75)
|
(81)
|
(84)
|
(86)
|
(96)
|
(106)
|
(112)
|
(120)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
0
|
1
|
1
|
1
|
3
|
7
|
9
|
10
|
11
|
9
|
9
|
12
|
14
|
15
|
17
|
20
|
23
|
25
|
27
|
27
|
28
|
|
| Other Non-Cash Items |
0
|
1
|
1
|
1
|
3
|
7
|
9
|
10
|
11
|
9
|
9
|
12
|
12
|
13
|
13
|
14
|
17
|
20
|
23
|
24
|
26
|
|
| Change in Working Capital |
1
|
0
|
1
|
2
|
(0)
|
2
|
(3)
|
(5)
|
(6)
|
(8)
|
(2)
|
(2)
|
6
|
(0)
|
5
|
5
|
(1)
|
3
|
(4)
|
(4)
|
(2)
|
|
| Cash from Operating Activities |
(8)
N/A
|
(11)
-42%
|
(14)
-25%
|
(17)
-25%
|
(24)
-38%
|
(28)
-18%
|
(41)
-46%
|
(47)
-16%
|
(50)
-6%
|
(51)
-2%
|
(44)
+15%
|
(49)
-11%
|
(50)
-3%
|
(62)
-24%
|
(63)
-1%
|
(64)
-1%
|
(70)
-10%
|
(73)
-5%
|
(87)
-18%
|
(91)
-5%
|
(95)
-4%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(144)
|
(126)
|
(270)
|
(249)
|
(98)
|
(84)
|
82
|
45
|
73
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
N/A
|
(0)
-52%
|
(1)
-28%
|
(1)
-8%
|
(1)
-28%
|
(1)
-1%
|
(1)
+23%
|
(1)
+14%
|
(0)
+36%
|
(0)
+58%
|
(0)
-27%
|
(145)
-76 008%
|
(126)
+13%
|
(271)
-115%
|
(250)
+8%
|
(98)
+61%
|
(84)
+14%
|
81
N/A
|
45
-45%
|
72
+61%
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
23
|
130
|
130
|
313
|
311
|
181
|
181
|
(1)
|
1
|
1
|
1
|
1
|
2
|
202
|
202
|
202
|
203
|
4
|
4
|
4
|
8
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
(0)
|
(1)
|
(0)
|
(0)
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
23
N/A
|
130
+456%
|
129
-1%
|
313
+142%
|
311
0%
|
181
-42%
|
182
+0%
|
(1)
N/A
|
1
N/A
|
1
+22%
|
1
+44%
|
1
+9%
|
2
+27%
|
201
+13 008%
|
201
+0%
|
202
+0%
|
202
+0%
|
4
-98%
|
4
+5%
|
4
-2%
|
8
+96%
|
|
| Change in Cash | ||||||||||||||||||||||
| Net Change in Cash |
15
N/A
|
119
+675%
|
115
-3%
|
295
+156%
|
287
-3%
|
153
-47%
|
141
-8%
|
(49)
N/A
|
(50)
-3%
|
(51)
-1%
|
(43)
+16%
|
(48)
-11%
|
(193)
-306%
|
13
N/A
|
(133)
N/A
|
(112)
+16%
|
34
N/A
|
(154)
N/A
|
(1)
+99%
|
(42)
-4 094%
|
(15)
+65%
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
(8)
N/A
|
(11)
-41%
|
(14)
-26%
|
(18)
-25%
|
(24)
-37%
|
(29)
-18%
|
(42)
-45%
|
(48)
-15%
|
(51)
-6%
|
(52)
-1%
|
(44)
+15%
|
(49)
-11%
|
(51)
-4%
|
(63)
-24%
|
(64)
-2%
|
(65)
-1%
|
(70)
-8%
|
(74)
-5%
|
(87)
-18%
|
(91)
-5%
|
(95)
-4%
|
|
Switch to:
Switch to:
See Also
Discover More
